Global Longlife Hospital and Research Limited (BOM:543520)
India flag India · Delayed Price · Currency is INR
12.00
-0.21 (-1.72%)
At close: May 27, 2026

BOM:543520 Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
-5.77135.15235.02328.15
Other Revenue
-0.030.040.040.21
-5.8135.18235.05328.36
Revenue Growth (YoY)
--95.71%-42.49%-28.42%0.41%
Cost of Revenue
1.9434.25118.74172.21214.77
Gross Profit
-1.94-28.4516.4562.84113.59
Selling, General & Admin
-0.420.130.280.75
Other Operating Expenses
7.9912.518.7421.8529.65
Operating Expenses
7.9917.7431.3633.841.84
Operating Income
-9.93-46.19-14.9229.0571.75
Interest Expense
-0-2.92-7.04-3.2-15.08
Interest & Investment Income
-1.30.591.262.04
Other Non Operating Income (Expenses)
0.05-0.03-0.71-0.03-1
EBT Excluding Unusual Items
-9.88-47.84-22.0827.0857.71
Gain (Loss) on Sale of Investments
-5.71---
Gain (Loss) on Sale of Assets
-43.12-0.58--0.61
Pretax Income
-9.880.99-22.6627.0857.1
Income Tax Expense
7.32-1-0.788.821.36
Net Income
-17.21.99-21.8818.2835.74
Net Income to Common
-17.21.99-21.8818.2835.74
Net Income Growth
----48.86%74.59%
Shares Outstanding (Basic)
101111107
Shares Outstanding (Diluted)
101111107
Shares Change (YoY)
-0.14%-3.11%45.48%-
EPS (Basic)
-1.640.19-2.081.795.11
EPS (Diluted)
-1.640.19-2.081.795.11
EPS Growth
----64.94%74.85%
Free Cash Flow
-45.1122.48-61.21-424.289.49
Free Cash Flow Per Share
-4.3011.66-5.83-41.6612.79
Gross Margin
--12.17%26.74%34.59%
Operating Margin
--796.35%-11.03%12.36%21.85%
Profit Margin
-34.26%-16.19%7.78%10.88%
Free Cash Flow Margin
-2111.78%-45.28%-180.47%27.25%
EBITDA
-5.12-41.38-2.4340.7183.19
EBITDA Margin
---1.80%17.32%25.33%
D&A For EBITDA
4.814.8112.4911.6711.43
EBIT
-9.93-46.19-14.9229.0571.75
EBIT Margin
---11.03%12.36%21.85%
Effective Tax Rate
---32.51%37.41%
Revenue as Reported
0.0555.93135.78237.4330.43
Source: S&P Global Market Intelligence. Standard template. Financial Sources.